We at XSeed have been thinking a lot about the near future – not about the deep and disruptive social and economic impacts of ongoing innovations in autonomous and semi-autonomous systems, deep learning, bots and robots, VR and AR (all areas where we have been deploying capital for some time). Rather, we’ve been thinking about where the current economicRead More
Author: XSeed Capital
One of XSeed’s recent Executives-in-Residence (EIR) and former portfolio executive, Sharon Goldstein, shared some insights about her career, her time at XSeed as an EIR and new position at ShipHawk.
Tell us a bit about you:
I’ve always been drawn to audacious opportunities with high barriers to entry. My first role out of business school was asRead More
Ford made headlines at CES this week when it announced a major partnership that will integrate Amazon’s technology into its cars, also following rumors that the company is workingRead More
We are extremely excited to announce that Lex Machina has been acquired by LexisNexis of the RELX Group (NYSE:RELX). XSeed could not be happier for the management team and employees who built a company that is enabling lawyers and corporations to use data analytics to figure out how to make business decisions in ways that were previously impossible to do.Read More
Where Does Your Product Fit In The Market? The Best Entrepreneurs Marry Conviction With AdaptabilityAugust 24, 2015
This XSeed article was written by Theresa Johnston and originally appeared on the Stanford Graduate School of Business website.
Say you’re an entrepreneur and your product is getting little traction. You could go back to the drawing board and re-engineer it. It might make more sense, though, to rethink your market, says venture capitalist Alan ChiuRead More
One of our goals at XSeed is to invest in entrepreneurs who pursue risky, paradigm changing ideas to solve big problems that seem intractable using established approaches. Rapid, cost-effective diagnosis and data-guided treatment of antibiotic resistant diseases is one such problem – causing about 25,000 deaths and over 2 million illnesses a year in the U.S. alone, with new,Read More
As a partner at XSeed Capital, an early-stage investment firm in Silicon Valley, Robert Siegel knows how quickly poor management of human resources can sink a fledging business.
“The single largestRead More
The spate of high profile cyberattacks have raised the awareness of cybersecurity to the board level and encouraged venture capitalists to pour money into this sector. In 2013 the industry received $1.7 billion of VC money across 240 deals,Read More
XSeed Capital is thrilled with the acquisition of CirroSecure by Palo Alto Networks (PANW), which was announced today by both companies. When we first met co-founders Vikrant Karvir and Nishant Doshi 18 months ago, we were extremely impressed with their understanding of the security landscape and their strategy to differentiate in a crowded market segment. CirroSecure’s tenacious focusRead More
What does it take to be a product manager?
XSeed Capital Partner Alan Chiu (MSx ‘11) kicked off his Stanford GSB talk, “Career Pathways in Product Management,” by first exploring the definitionRead More